Overview

A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the long-term efficacy of nebivolol monotherapy in patients with stage 1 or stage 2 hypertension after the withdrawal of active medication.
Phase:
Phase 4
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Nebivolol